Longboard Pharmaceuticals Statistics
Total Valuation
LBPH has a market cap or net worth of $703.60 million. The enterprise value is $645.31 million.
| Market Cap | 703.60M |
| Enterprise Value | 645.31M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LBPH has 36.02 million shares outstanding. The number of shares has increased by 32.51% in one year.
| Shares Outstanding | 36.02M |
| Shares Change (YoY) | +32.51% |
| Shares Change (QoQ) | +2.20% |
| Owned by Insiders (%) | 1.09% |
| Owned by Institutions (%) | 64.70% |
| Float | 23.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 16.94 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.14, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.14 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -97.50% and return on invested capital (ROIC) is -137.11%.
| Return on Equity (ROE) | -97.50% |
| Return on Assets (ROA) | -85.20% |
| Return on Capital (ROIC) | -137.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.09M |
| Employee Count | 50 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +162.26% in the last 52 weeks. The beta is 1.26, so LBPH's price volatility has been higher than the market average.
| Beta (1Y) | 1.26 |
| 52-Week Price Change | +162.26% |
| 50-Day Moving Average | 20.04 |
| 200-Day Moving Average | 11.82 |
| Relative Strength Index (RSI) | 50.23 |
| Average Volume (30 Days) | 552,767 |
Short Selling Information
The latest short interest is 4.92 million, so 13.67% of the outstanding shares have been sold short.
| Short Interest | 4.92M |
| Short Previous Month | 4.95M |
| Short % of Shares Out | 13.67% |
| Short % of Float | 20.79% |
| Short Ratio (days to cover) | 10.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -56.76M |
| Pretax Income | -54.42M |
| Net Income | -54.42M |
| EBITDA | -54.42M |
| EBIT | -54.42M |
| Earnings Per Share (EPS) | -$2.39 |
Balance Sheet
The company has $48.50 million in cash and $475,000 in debt, giving a net cash position of $48.02 million or $1.33 per share.
| Cash & Cash Equivalents | 48.50M |
| Total Debt | 475,000 |
| Net Cash | 48.02M |
| Net Cash Per Share | $1.33 |
| Equity / Book Value | 40.92M |
| Book Value Per Share | 1.14 |
| Working Capital | 40.45M |
Cash Flow
| Operating Cash Flow | -50.87M |
| Capital Expenditures | n/a |
| Free Cash Flow | -50.87M |
| FCF Per Share | -$2.24 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LBPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.51% |
| Shareholder Yield | -32.51% |
| Earnings Yield | -7.85% |
| FCF Yield | -7.34% |
Analyst Forecast
The average price target for LBPH is $36.14, which is 85.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.14 |
| Price Target Difference | 85.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -28.43% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |